Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset.

Hamadjida A, Nuara SG, Bédard D, Frouni I, Kwan C, Gourdon JC, Huot P.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Aug 7. doi: 10.1007/s00210-018-1549-6. [Epub ahead of print]

PMID:
30088028
2.

5-HT1A agonists and dyskinesia in Parkinson's disease: a pharmacological perspective.

Huot P.

Neurodegener Dis Manag. 2018 Jul 24. doi: 10.2217/nmt-2018-0017. [Epub ahead of print] No abstract available.

PMID:
30040029
3.

Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmoset.

Gaudette F, Hamadjida A, Bédard D, Nuara SG, Gourdon JC, Michaud V, Beaudry F, Huot P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Sep 1;1093-1094:1-7. doi: 10.1016/j.jchromb.2018.06.036. Epub 2018 Jun 19.

PMID:
29980099
4.

The highly selective 5-HT2A antagonist EMD-281,014 reduces dyskinesia and psychosis in the l-DOPA-treated parkinsonian marmoset.

Hamadjida A, Nuara SG, Bédard D, Gaudette F, Beaudry F, Gourdon JC, Huot P.

Neuropharmacology. 2018 Sep 1;139:61-67. doi: 10.1016/j.neuropharm.2018.06.038. Epub 2018 Jun 30.

PMID:
29969592
5.

Predictive Value of Parkinsonian Primates in Pharmacologic Studies: A Comparison between the Macaque, Marmoset, and Squirrel Monkey.

Veyres N, Hamadjida A, Huot P.

J Pharmacol Exp Ther. 2018 May;365(2):379-397. doi: 10.1124/jpet.117.247171. Epub 2018 Mar 9.

PMID:
29523699
6.

Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's disease.

Hamadjida A, Nuara SG, Gourdon JC, Huot P.

J Neural Transm (Vienna). 2018 Sep;125(9):1355-1360. doi: 10.1007/s00702-017-1830-8. Epub 2017 Dec 15.

PMID:
29247391
7.

The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset.

Hamadjida A, Nuara SG, Gourdon JC, Huot P.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:367-371. doi: 10.1016/j.pnpbp.2017.09.001. Epub 2017 Sep 5. No abstract available.

PMID:
28882428
8.

Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method to quantify LY-354,740 in rat and marmoset plasma.

Gaudette F, Hamadjida A, Bédard D, Nuara SG, Beaudry F, Huot P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Sep 1;1061-1062:392-398. doi: 10.1016/j.jchromb.2017.07.007. Epub 2017 Jul 15.

PMID:
28802219
9.

The effect of dairy and nondairy beverages consumed with high glycemic cereal on subjective appetite, food intake, and postprandial glycemia in young adults.

Law M, Huot PSP, Lee YT, Vien S, Luhovyy BL, Anderson GH.

Appl Physiol Nutr Metab. 2017 Nov;42(11):1201-1209. doi: 10.1139/apnm-2017-0135. Epub 2017 Jul 31.

PMID:
28759734
10.

Serotonergic Approaches in Parkinson's Disease: Translational Perspectives, an Update.

Huot P, Sgambato-Faure V, Fox SH, McCreary AC.

ACS Chem Neurosci. 2017 May 17;8(5):973-986. doi: 10.1021/acschemneuro.6b00440. Epub 2017 May 5. Review.

PMID:
28460160
11.

The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.

Hamadjida A, Nuara SG, Veyres N, Frouni I, Kwan C, Sid-Otmane L, Harraka MJ, Gourdon JC, Huot P.

Psychopharmacology (Berl). 2017 Mar;234(6):905-911. doi: 10.1007/s00213-017-4530-z. Epub 2017 Jan 27.

PMID:
28130646
12.

Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.

Selfani K, Soland VL, Chouinard S, Huot P.

Neurologist. 2017 Jan;22(1):24-28. doi: 10.1097/NRL.0000000000000096.

PMID:
28009769
13.

Maternal fat-soluble vitamins, brain development, and regulation of feeding behavior: an overview of research.

Sánchez-Hernández D, Anderson GH, Poon AN, Pannia E, Cho CE, Huot PSP, Kubant R.

Nutr Res. 2016 Oct;36(10):1045-1054. doi: 10.1016/j.nutres.2016.09.009. Epub 2016 Sep 17. Review.

PMID:
27865346
14.

Effects of Axial Traction during Direct MR-Arthrography of the Wrist in Sports Injuries.

Dallaudière B, Moreau-Durieux MH, Larbi A, Perozziello A, Huot P, Meyer P, Pesquer L.

J Belg Soc Radiol. 2016 Jul 29;100(1):72. doi: 10.5334/jbr-btr.918.

15.

Task-specific oro-lingual tremor following gingival grafting surgery.

Carpentier A, Selfani K, Huot P.

J Neurol Sci. 2016 Aug 15;367:24-5. doi: 10.1016/j.jns.2016.05.043. Epub 2016 May 21. No abstract available.

PMID:
27423558
16.

Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical Trials.

Huot P, Fox SH, Brotchie JM.

J Pharmacol Exp Ther. 2016 Jun;357(3):562-9. doi: 10.1124/jpet.116.232371. Epub 2016 Apr 13. Review.

17.

Maternal and postweaning folic acid supplementation interact to influence body weight, insulin resistance, and food intake regulatory gene expression in rat offspring in a sex-specific manner.

Huot PS, Ly A, Szeto IM, Reza-López SA, Cho D, Kim YI, Anderson GH.

Appl Physiol Nutr Metab. 2016 Apr;41(4):411-20. doi: 10.1139/apnm-2015-0503. Epub 2015 Dec 10.

PMID:
26989972
18.

Role of maternal vitamins in programming health and chronic disease.

Pannia E, Cho CE, Kubant R, Sánchez-Hernández D, Huot PS, Harvey Anderson G.

Nutr Rev. 2016 Mar;74(3):166-80. doi: 10.1093/nutrit/nuv103. Epub 2016 Feb 16. Review. Erratum in: Nutr Rev. 2016 Dec;74(12 ):785.

19.

The pons and human affective processing--Implications for Parkinson's disease.

Huot P.

EBioMedicine. 2015 Nov 2;2(11):1592-3. doi: 10.1016/j.ebiom.2015.10.031. eCollection 2015 Nov. No abstract available.

20.

A Man With Persistent Dopamine Agonist Withdrawal Syndrome After 7 Years Being Off Dopamine Agonists.

Huynh NT, Sid-Otmane L, Panisset M, Huot P.

Can J Neurol Sci. 2016 Nov;43(6):859-860. Epub 2016 Feb 4. No abstract available.

PMID:
26842385
21.

A comparison of effects of lard and hydrogenated vegetable shortening on the development of high-fat diet-induced obesity in rats.

Kubant R, Poon AN, Sánchez-Hernández D, Domenichiello AF, Huot PS, Pannia E, Cho CE, Hunschede S, Bazinet RP, Anderson GH.

Nutr Diabetes. 2015 Dec 14;5:e188. doi: 10.1038/nutd.2015.40.

22.

The pons and human affective processing - Implications for Parkinson's disease.

Huot P.

EBioMedicine. 2015 Nov;2(11):1592-1593. doi: 10.1016/j.ebiom.2015.10.031. Epub 2015 Nov 2. No abstract available.

23.

High vitamin A intake during pregnancy modifies dopaminergic reward system and decreases preference for sucrose in Wistar rat offspring.

Sánchez-Hernández D, Poon AN, Kubant R, Kim H, Huot PS, Cho CE, Pannia E, Reza-López SA, Pausova Z, Bazinet RP, Anderson GH.

J Nutr Biochem. 2016 Jan;27:104-11. doi: 10.1016/j.jnutbio.2015.08.020. Epub 2015 Aug 28.

PMID:
26456562
24.

Serotonin/dopamine transporter ratio as a predictor of L-dopa-induced dyskinesia.

Huot P, Hutchison WD.

Neurology. 2015 Sep 8;85(10):840-1. doi: 10.1212/WNL.0000000000001915. Epub 2015 Aug 7. No abstract available.

PMID:
26253446
25.

The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque.

Huot P, Johnston TH, Fox SH, Newman-Tancredi A, Brotchie JM.

Neuropharmacology. 2015 Oct;97:306-11. doi: 10.1016/j.neuropharm.2015.05.033. Epub 2015 Jun 10.

PMID:
26071982
26.

Monoamine reuptake inhibitors in Parkinson's disease.

Huot P, Fox SH, Brotchie JM.

Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25. Review.

27.

A gestational diet high in fat-soluble vitamins alters expression of genes in brain pathways and reduces sucrose preference, but not food intake, in Wistar male rat offspring.

Sanchez-Hernandez D, Poon AN, Kubant R, Kim H, Huot PS, Cho CE, Pannia E, Pausova Z, Anderson GH.

Appl Physiol Nutr Metab. 2015 Apr;40(4):424-31. doi: 10.1139/apnm-2014-0480. Epub 2015 Mar 19.

28.

L-DOPA-induced dyskinesia, is striatal dopamine depletion a requisite?

Huot P.

J Neurol Sci. 2015 Apr 15;351(1-2):9-12. doi: 10.1016/j.jns.2015.02.041. Epub 2015 Mar 1. Review.

PMID:
25758471
29.

Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: results of a pilot study.

Huot P, Johnston TH, Fox SH, Brotchie JM.

Synapse. 2015 Mar;69(3):99-102. doi: 10.1002/syn.21801.

PMID:
25559284
30.

Methyl vitamins contribute to obesogenic effects of a high multivitamin gestational diet and epigenetic alterations in hypothalamic feeding pathways in Wistar rat offspring.

Cho CE, Pannia E, Huot PS, Sánchez-Hernández D, Kubant R, Dodington DW, Ward WE, Bazinet RP, Anderson GH.

Mol Nutr Food Res. 2015 Mar;59(3):476-89. doi: 10.1002/mnfr.201400663. Epub 2015 Jan 14.

PMID:
25488374
31.

Propranolol-induced Somnambulism: A Case-report in a Patient with Essential Tremor.

Huynh NT, Huot P.

Can J Neurol Sci. 2014 Nov;41(6):787-8. doi: 10.1017/cjn.2014.101. Epub 2014 Oct 30. No abstract available.

PMID:
25376236
32.

L-745,870 reduces the expression of abnormal involuntary movements in the 6-OHDA-lesioned rat.

Huot P, Johnston TH, Koprich JB, Espinosa MC, Reyes MG, Fox SH, Brotchie JM.

Behav Pharmacol. 2015 Feb;26(1-2):101-8. doi: 10.1097/FBP.0000000000000096.

PMID:
25303957
33.

A generalised sensation of coldness following introduction of rosuvastatin therapy.

Huynh NT, Huot P.

BMJ Case Rep. 2014 Oct 9;2014. pii: bcr2014205987. doi: 10.1136/bcr-2014-205987.

34.

A high multivitamin diet fed to Wistar rat dams during pregnancy increases maternal weight gain later in life and alters homeostatic, hedonic and peripheral regulatory systems of energy balance.

Pannia E, Cho CE, Kubant R, Sánchez-Hernández D, Huot PS, Chatterjee D, Fleming A, Anderson GH.

Behav Brain Res. 2015 Feb 1;278:1-11. doi: 10.1016/j.bbr.2014.09.019. Epub 2014 Sep 28.

PMID:
25264184
35.

A woman with functional tremor treated with L-DOPA for 14 years.

Huynh NT, Huot P.

J Neurol Sci. 2014 Nov 15;346(1-2):358-9. doi: 10.1016/j.jns.2014.08.045. Epub 2014 Sep 6. No abstract available.

PMID:
25218418
36.

Increasing vitamin A in post-weaning diets reduces food intake and body weight and modifies gene expression in brains of male rats born to dams fed a high multivitamin diet.

Sánchez-Hernández D, Cho CE, Kubant R, Reza-López SA, Poon AN, Wang J, Huot PS, Smith CE, Anderson GH.

J Nutr Biochem. 2014 Oct;25(10):991-6. doi: 10.1016/j.jnutbio.2014.05.002. Epub 2014 Jun 2.

PMID:
24993918
37.

UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.

Huot P, Johnston TH, Lewis KD, Koprich JB, Reyes MG, Fox SH, Piggott MJ, Brotchie JM.

Neuropharmacology. 2014 Jul;82:76-87. doi: 10.1016/j.neuropharm.2014.01.012. Epub 2014 Jan 18.

PMID:
24447715
38.

The serotonergic system in motor and non-motor manifestations of Parkinson's disease.

Huot P, Fox SH.

Exp Brain Res. 2013 Oct;230(4):463-76. doi: 10.1007/s00221-013-3621-2. Epub 2013 Jun 28. Review.

PMID:
23811734
39.

High folate gestational and post-weaning diets alter hypothalamic feeding pathways by DNA methylation in Wistar rat offspring.

Cho CE, Sánchez-Hernández D, Reza-López SA, Huot PS, Kim YI, Anderson GH.

Epigenetics. 2013 Jul;8(7):710-9. doi: 10.4161/epi.24948. Epub 2013 May 14.

40.

High Folic Acid Intake during Pregnancy Lowers Body Weight and Reduces Femoral Area and Strength in Female Rat Offspring.

Huot PS, Dodington DW, Mollard RC, Reza-López SA, Sánchez-Hernández D, Cho CE, Kuk J, Ward WE, Anderson GH.

J Osteoporos. 2013;2013:154109. doi: 10.1155/2013/154109. Epub 2013 May 27.

41.

TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque.

Johnston TH, Huot P, Fox SH, Koprich JB, Szeliga KT, James JW, Graef JD, Letchworth SR, Jordan KG, Hill MP, Brotchie JM.

Neuropharmacology. 2013 Oct;73:337-47. doi: 10.1016/j.neuropharm.2013.06.005. Epub 2013 Jun 14.

PMID:
23770260
42.

The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.

Huot P, Johnston TH, Koprich JB, Fox SH, Brotchie JM.

Pharmacol Rev. 2013 Jan 10;65(1):171-222. doi: 10.1124/pr.111.005678. Print 2013 Jan. Review.

43.

The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.

Koprich JB, Huot P, Fox SH, Jarvie K, Lang AE, Seeman P, Brotchie JM.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:151-6. doi: 10.1016/j.pnpbp.2012.12.008. Epub 2013 Jan 7.

PMID:
23306217
44.

Obesogenic phenotype of offspring of dams fed a high multivitamin diet is prevented by a post-weaning high multivitamin or high folate diet.

Cho CE, Sánchez-Hernández D, Reza-López SA, Huot PS, Kim YI, Anderson GH.

Int J Obes (Lond). 2013 Sep;37(9):1177-82. doi: 10.1038/ijo.2012.210. Epub 2013 Jan 8.

45.

Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque.

Huot P, Johnston TH, Snoeren T, Koprich JB, Hill MP, Fox SH, Brotchie JM.

Eur J Neurosci. 2013 Mar;37(5):831-8. doi: 10.1111/ejn.12093. Epub 2013 Jan 3.

PMID:
23281915
46.

The monoamine re-uptake inhibitor UWA-101 improves motor fluctuations in the MPTP-lesioned common marmoset.

Huot P, Johnston TH, Gandy MN, Reyes MG, Fox SH, Piggott MJ, Brotchie JM.

PLoS One. 2012;7(9):e45587. doi: 10.1371/journal.pone.0045587. Epub 2012 Sep 20.

47.

RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study.

Johnston TH, Huot P, Damude S, Fox SH, Jones SW, Rusche JR, Brotchie JM.

Parkinsonism Relat Disord. 2013 Feb;19(2):260-4. doi: 10.1016/j.parkreldis.2012.07.001. Epub 2012 Aug 14.

PMID:
22901956
48.

L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease.

Huot P, Johnston TH, Koprich JB, Fox SH, Brotchie JM.

Neuropharmacology. 2012 Oct;63(5):829-36. doi: 10.1016/j.neuropharm.2012.06.012. Epub 2012 Jun 18.

PMID:
22722022
49.

L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.

Huot P, Johnston TH, Koprich JB, Aman A, Fox SH, Brotchie JM.

J Pharmacol Exp Ther. 2012 Aug;342(2):576-85. doi: 10.1124/jpet.112.195693. Epub 2012 May 22.

50.

Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease.

Huot P, Johnston TH, Visanji NP, Darr T, Pires D, Hazrati LN, Brotchie JM, Fox SH.

Mov Disord. 2012 May;27(6):735-42. doi: 10.1002/mds.24964. Epub 2012 Mar 14.

PMID:
22419526

Supplemental Content

Support Center